WallStreetZenWallStreetZen

NYSE: ANRO
Alto Neuroscience Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ANRO

Based on 3 analysts offering 12 month price targets for Alto Neuroscience Inc.
Min Forecast
$32.00+125.67%
Avg Forecast
$32.33+128.02%
Max Forecast
$33.00+132.72%

Should I buy or sell ANRO stock?

Based on 3 analysts offering ratings for Alto Neuroscience Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ANRO stock forecasts and price targets.

ANRO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-25
lockedlocked$00.00+00.00%2024-02-27
lockedlocked$00.00+00.00%2024-02-27

1 of 1

ANRO revenue forecast

What is ANRO's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$4.6M
Avg 2 year Forecast
$120.0M

ANRO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANRO$14.18$32.33+128.02%Strong Buy
CBUS$15.84$25.00+57.83%Buy
MREO$2.74$6.50+137.23%Strong Buy
NGNE$29.96$43.00+43.52%Strong Buy
ADPT$2.60$6.00+130.77%Strong Buy
View Top Biotech Stocks

Alto Neuroscience Stock Forecast FAQ

Is Alto Neuroscience Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSE: ANRO) stock is to Strong Buy ANRO stock.

Out of 3 analysts, 2 (66.67%) are recommending ANRO as a Strong Buy, 1 (33.33%) are recommending ANRO as a Buy, 0 (0%) are recommending ANRO as a Hold, 0 (0%) are recommending ANRO as a Sell, and 0 (0%) are recommending ANRO as a Strong Sell.

If you're new to stock investing, here's how to buy Alto Neuroscience stock.

What is ANRO's revenue growth forecast for 2028-2029?

(NYSE: ANRO) Alto Neuroscience's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Alto Neuroscience's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast ANRO's revenue for 2028 to be $122,322,145, with the lowest ANRO revenue forecast at $122,322,145, and the highest ANRO revenue forecast at $122,322,145.

In 2029, ANRO is forecast to generate $3,225,003,200 in revenue, with the lowest revenue forecast at $3,225,003,200 and the highest revenue forecast at $3,225,003,200.

What is ANRO's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ANRO price target, the average ANRO price target is $32.33, with the highest ANRO stock price forecast at $33.00 and the lowest ANRO stock price forecast at $32.00.

On average, Wall Street analysts predict that Alto Neuroscience's share price could reach $32.33 by Mar 25, 2025. The average Alto Neuroscience stock price prediction forecasts a potential upside of 128.02% from the current ANRO share price of $14.18.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.